Stockscreener 앱 받기
99.29
1.20%
1.18
시간 외 거래:
100.00
0.71
+0.72%
Revolution Medicines Inc 주식(RVMD)의 최신 뉴스
Wei Lin, chief medical officer, sells $206k in Revolution Medicines - Investing.com Australia
Revolution Medicines (NASDAQ: RVMD) CMO sells 2,073 shares for tax withholding - Stock Titan
Revolution Medicines (RVMD) officer sells 4,302 shares under 10b5-1 plan - Stock Titan
Revolution Medicines (RVMD) director sells 12,871 shares in 10b5-1 trade - Stock Titan
CFO of Revolution Medicines (NASDAQ: RVMD) sells 2,753 shares - Stock Titan
Revolution Medicines (RVMD) counsel sells 2,958 pre-planned shares - Stock Titan
Morgan Stanley schedules sale of RVMD (NASDAQ: RVMD) RSUs, prior insider sales listed - Stock Titan
Revolution Medicines (RVMD) Among Top Biotech M&A Targets - GuruFocus
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - The Motley Fool
RBC names top M&A candidates in biotech (RVMD:NASDAQ) - Seeking Alpha
Revolution Medicines, Inc. (RVMD) net loss widens amid progress on clinical trial programs - MSN
Piper Sandler Initiates Coverage of Revolution Medicines (RVMD) with Overweight Recommendation - MSN
Piper Sandler Initiates Coverage of Revolution Medicines (RVMD) with an Overweight Rating - MSN
Stifel Reiterates Revolution Medicines (RVMD) Buy Recommendation - MSN
Wells Fargo Initiates Coverage of Revolution Medicines (RVMD) with Overweight Recommendation - MSN
Revolution Medicines Secures $2 Billion Flexible Financing Deal with Royalty Pharma - MSN
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting - Bitget
Revolution Medicines Showcases RAS(ON) Inhibitor Pipeline Advances at AACR Annual Meeting 2026 - Quiver Quantitative
Revolution Medicines to Showcase Progress Across RAS(ON) - GlobeNewswire
Revolution Medicines brings lung and pancreatic cancer trial data to AACR 2026 - Stock Titan
Algert Global LLC Boosts Position in Revolution Medicines, Inc. $RVMD - MarketBeat
RVMD: Jefferies Raises Price Target for Revolution Medicines to $140 | RVMD Stock News - GuruFocus
RVMD SEC FilingsRevolution Medicines, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Revolution Medicines (NASDAQ:RVMD) Now Covered by Analysts at Jefferies Financial Group - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Acquired by HighVista Strategies LLC - MarketBeat
Holocene Advisors LP Sells 195,669 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD is Farallon Capital Management LLC's 6th Largest Position - MarketBeat
Decheng Capital LLC Reduces Stock Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD is Boxer Capital Management LLC's 3rd Largest Position - MarketBeat
Casdin Capital LLC Cuts Stake in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Bought by Checkpoint Capital L.P. - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Acquired by Baker BROS. Advisors LP - MarketBeat
Integral Health Asset Management LLC Has $18.68 Million Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
General Atlantic L.P. Acquires New Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Director files Form 144 to sell RVMD shares (NASDAQ: RVMD) - Stock Titan
ETRADE (RVMD) Form 144 lists RSU grants and prospective resale activity - Stock Titan
Stephen Kelsey sold 5,447 shares — Revolution Medicines (NASDAQ: RVMD) - Stock Titan
Margaret Horn sells 75,000 shares (NASDAQ: RVMD) in Form 144 filing - Stock Titan
Mark Goldsmith sells shares at Revolution Medicines (NASDAQ: RVMD) - Stock Titan
Insider sales reported at Revolution Medicines (NASDAQ: RVMD) — specific proceeds disclosed - Stock Titan
[144] Revolution Medicines, Inc. SEC Filing - Stock Titan
RVMD Stock Price, Quote & Chart | REVOLUTION MEDICINES INC (NASDAQ:RVMD) - ChartMill
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines (RVMD) price target increased by 10.10% to 92.82 - MSN
A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum - Yahoo Finance
Revolution Medicines’ Daraxonrasib Granted FDA Breakthrough Therapy Designation for Pancreatic Cancer with KRAS G12 Mutations - MSN
Revolution Medicines gets FDA Breakthrough Therapy status for daraxonrasib - MSN
Why Revolution Medicines Inc. Equity Warrant stock is trending among retail tradersJuly 2025 Macro Moves & Daily Stock Momentum Reports - Naître et grandir
Revolution Medicines (RVMD) director Elizabeth Anderson gifts 30,000 shares - Stock Titan
Earnings Report: Is Revolution Medicines Inc affected by consumer sentimentEarnings Recap Summary & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
This One Data Readout Could Make Or Break Revolution Medicines (NASDAQ:RVMD) - Seeking Alpha
Is Revolution Medicines (RVMD) Pricing Fully Reflect Its Surging Oncology Pipeline Potential - simplywall.st
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights - Yahoo Finance
Handelsbanken Fonder AB Grows Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines Insider Sold Shares Worth $3,644,354, According to a Recent SEC Filing - marketscreener.com
Revolution Medicines (NASDAQ:RVMD) Insider Mark Goldsmith Sells 30,000 Shares - MarketBeat
Revolution Medicines director Goldsmith sells shares worth $3.64 million - Investing.com Australia
Equity awards increase Wei Lin’s stake in Revolution Medicines (RVMD) - Stock Titan
Revolution Medicines (RVMD) grants CFO new stock and option awards - Stock Titan
Revolution Medicines (RVMD) COO awarded new stock and option grants - Stock Titan
Revolution Medicines at TD Cowen Conference: Strategic Insights on Cancer Trials - Investing.com Australia
Revolution Medicines, Inc. $RVMD Shares Purchased by Legato Capital Management LLC - MarketBeat
Revolution Medicines, Inc. (NASDAQ:RVMD) Receives Average Rating of "Buy" from Brokerages - MarketBeat
RVMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revolution Medicines Doubles Down on Costly RAS Push - TipRanks
Broker proposes sale of 3,000 RVMD shares (NASDAQ: RVMD) — Form 144 - Stock Titan
Mark A. Goldsmith sells 15,394 shares (RVMD) via Form 144 - Stock Titan
0.00%
0.06%
자본화:
|
볼륨(24시간):